Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Iran conflict underscores dairy’s early-season risk warnings
Primary Sector

Iran conflict underscores dairy’s early-season risk warnings

The Israel-Iran war raises logistics risks for dairy but prices likely to remain steady.

Fletcher Building’s FY result won’t be pretty
Markets

Fletcher Building’s FY result won’t be pretty

No dividends will be paid until the debt target is met. 

Fletcher’s down 3.6%; NZX misses ceasefire rally
Markets Market Close

Fletcher’s down 3.6%; NZX misses ceasefire rally

 Channel Infrastructure has benefited from tensions in the Middle East, an analyst said.

Gregor Thompson 24 Jun 2025
Fletcher's restructuring, impairment costs could hit $781m
Infrastructure

Fletcher's restructuring, impairment costs could hit $781m

It expects ebit of $370m to $375m before significant items. 

Rebecca Howard 24 Jun 2025